Jean-Emmanuel Sarry
Jean-Emmanuel Sarry is an expert in Hematology at Centre Hospitalier Universitaire de Toulouse (France). As of October 2026, ScienceLeadR ranks Jean-Emmanuel Sarry in the top 1% of experts worldwide for Leukemia. Jean-Emmanuel Sarry has authored 165 publications, the most recent in 2026. SLR score: 834 (community average: 125). How the SLR is computed.
LeadR Profile
Hematology
Subspecialties: Oncology - Geriatrics - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1994 - 2026
Number : 165
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist. PMID 42835773 — cells, leukemia, cell line, research, therapeutics | Hemasphere | 2026 | 0 |
| LY3410738, a Covalent Inhibitor of Mutant IDH1/2, is Effective in Acute Myeloid Leukemia Preclinical Models. PMID 42490065 — glioma, blood, leukemia, leukemia, myeloid, acute, leukemia, myeloid, mutation | Blood Cancer Discov | 2026 | 0 |
| Accelerated Epigenetic and Inflammatory Aging and Intrinsic Capacity. PMID 42475093 — aging, cohort studies, longevity, clinical medicine | JAMA Netw Open | 2026 | 1 |
| Hitting AML where it breathes: the peroxisome fat trap. PMID 42275119 — hematology, peroxisomes | Blood | 2026 | 0 |
| Glycolysis and glycolytic enzymes in acute myeloid leukemia: Warburg and beyond. PMID 42244861 — cells, neoplasms, leukemia, leukemia, myeloid, acute, enzymes, leukemia, myeloid, therapeutics | Front Pharmacol | 2026 | 0 |
LeadR Networks
Main global connection map